Ticker Symbol: CUE

Cue Biopharma Inc

$17.07 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001645460

Company Profile

Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Standard Industrial Classification Code (SIC code): 2834

Address: 21 Erie St

Website: www.cuebiopharma.com

CEO: Daniel Passeri

Tags:

Health Technology
Biotechnology

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $2.06

Change: -$0.04 ( -2.14%)

Days Range: $1.98 - $2.09

Beta: 1.31

52wk. High: $5.12

52wk. Low: $1.81

Ytd. Change -28.28%

50 Day Moving Average: $2.31

200 Day Moving Average: $3.43

Shares Outstanding: 44959548

Valuation

Market Cap: 9.3B

PE Ratio: -

EPS (TTM): -1.26

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A